GlaxoSmithKline and Vir's Xevudy has become the latest COVID-19 antibody therapy to have its use restricted by the FDA as a result of waning activity against new variants of the virus. The US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback